Treatment of Telangiectasia: Comparison of Sclerosing Agents
- 1 November 1987
- journal article
- clinical trial
- Published by Wiley in The Journal of Dermatologic Surgery and Oncology
- Vol. 13 (11) , 1181-1186
- https://doi.org/10.1111/j.1524-4725.1987.tb02429.x
Abstract
A double‐blind, double‐paired comparison, placebo‐controlled study was undertaken to determine the optimal agent for sclerotherapy of spider telangiec‐tasias of the lower extremities. Sodium tetradecyl sulfate 0.5%, polidocanol 0.25%, heparsal, and normal saline control were evaluated in terms of clinical effectiveness and patient acceptance. Although all of the agents, except for the control, were effective, polidocanol was found to have the fewest adverse reactions and afforded the greatest patient comfort.Keywords
This publication has 10 references indexed in Scilit:
- Sclerosing Agents in the Treatment of TelangiectasiaArchives of Dermatology, 1987
- Treatment of telangiectasia: A reviewJournal of the American Academy of Dermatology, 1987
- A Mild Sclerosing Agent for TelangiectasiasThe Journal of Dermatologic Surgery and Oncology, 1985
- Techniques of Sclerotherapy for Sunburst Venous BlemishesThe Journal of Dermatologic Surgery and Oncology, 1985
- Allergic Dermatitis to Benzyl Alcohol in an Injectable SolutionArchives of Dermatology, 1984
- Use of the argon and carbon dioxide lasers for treatment of superficial venous varicosities of the lower extremityLasers in Surgery and Medicine, 1984
- Therapy for Superficial Telangiectasias of the Lower ExtremitiesThe Journal of Dermatologic Surgery and Oncology, 1982
- Therapy for essential cutaneous telangiectasiaPostgraduate Medicine, 1977
- Localized hirsuties following compression sclerotherapy with sodium tetradecyl sulphateBritish Journal of Surgery, 1974
- Cosmetic Management of Selected Skin Changes of the LegsSouthern Medical Journal, 1970